1. Home
  2. HUN vs TMDX Comparison

HUN vs TMDX Comparison

Compare HUN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUN
  • TMDX
  • Stock Information
  • Founded
  • HUN 1970
  • TMDX 1998
  • Country
  • HUN United States
  • TMDX United States
  • Employees
  • HUN N/A
  • TMDX N/A
  • Industry
  • HUN Major Chemicals
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • HUN Industrials
  • TMDX Health Care
  • Exchange
  • HUN Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • HUN 2.4B
  • TMDX 2.3B
  • IPO Year
  • HUN 2005
  • TMDX 2019
  • Fundamental
  • Price
  • HUN $12.05
  • TMDX $111.50
  • Analyst Decision
  • HUN Hold
  • TMDX Buy
  • Analyst Count
  • HUN 9
  • TMDX 10
  • Target Price
  • HUN $15.00
  • TMDX $122.89
  • AVG Volume (30 Days)
  • HUN 4.2M
  • TMDX 1.2M
  • Earning Date
  • HUN 05-01-2025
  • TMDX 05-08-2025
  • Dividend Yield
  • HUN 8.29%
  • TMDX N/A
  • EPS Growth
  • HUN N/A
  • TMDX N/A
  • EPS
  • HUN N/A
  • TMDX 1.41
  • Revenue
  • HUN $5,976,000,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • HUN $4.09
  • TMDX $25.33
  • Revenue Next Year
  • HUN $4.65
  • TMDX $20.53
  • P/E Ratio
  • HUN N/A
  • TMDX $79.36
  • Revenue Growth
  • HUN 0.02
  • TMDX 64.43
  • 52 Week Low
  • HUN $11.15
  • TMDX $55.00
  • 52 Week High
  • HUN $25.78
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • HUN 38.03
  • TMDX 78.52
  • Support Level
  • HUN $11.15
  • TMDX $92.49
  • Resistance Level
  • HUN $12.22
  • TMDX $95.71
  • Average True Range (ATR)
  • HUN 0.49
  • TMDX 4.79
  • MACD
  • HUN -0.02
  • TMDX 0.81
  • Stochastic Oscillator
  • HUN 32.19
  • TMDX 71.36

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: